Metabolite details
Reactome pathways
- No Reactome pathways listed for this metabolite.
Observed in studies
- Metabolite profile of mice hippocampus following Toxoplasma gondii infection
- Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
- Collagen induced arthritis in dba/1j mice associates with oxylipin changes in plasma
- Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
- Anti-anemia drug FG4592 retards the AKI to CKD transition by improving vascular regeneration and anti-oxidative capability (day 10)
- Lipid mediators of inflammation in BALF 3-19 days after infection with influenza.
- Lipid mediators of inflammation in BALF 6-19 days after infection with influenza.
- Lipid mediators of inflammation in BALF 3-11 days after infection with influenza.
- Lipid mediators of inflammation in BALF 3-13 days after infection with influenza.
- Effects of MeJA on Arabidopsis metabolome under endogenous JA deficiency
- Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
- Metabolic profilings of rat INS-1 β-cells under changing levels of essential amino acids
- Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
Observed in differential profiles
- G5_Phosphate_Buffered_Saline_7_days_vs_G2_Toxoplasma_gondii_PRU_7_days
- Control_vs_nsPEF_7_day
- Control_vs_CIA
- Control_vs_Lithogenic_Diet
- Sham_vs_UIR
- Mock_18_days_vs_X31_19_days
- Mock_19d_vs_PR8_19d
- G1_Mock_11_day_vs_G5_PR8_11_day
- G1_Mock_11_day_vs_G5_PR8_11_day
- Mock_13d_vs_PR8_13d
- G1_PBS_vs_G2_DSS
- WT_no_treatment_vs_opr3_8h
- G1_Control_vs_G2_Arginine_Addition
- Control_vs_ZYP_High_Dose